|
Atypical Neuroleptics
Citations 161-170 of 335 total displayed.
|
Past content
(since Jun 2002):
|
- Brief Reports
Double-Blind, Placebo-Controlled Study of Dialectical Behavior Therapy Plus Olanzapine for Borderline Personality Disorder
- Joaquim Soler, Juan Carlos Pascual, Josefa Campins, Judith Barrachina, Dolors Puigdemont, Enrique Alvarez, and Victor Pérez
Am J Psychiatry 2005; 162: 1221-1224.
[Abstract]
[Full text]
[PDF]
- Articles
Evidence for Onset of Antipsychotic Effects Within the First 24 Hours of Treatment
- Shitij Kapur, Tamara Arenovich, Ofer Agid, Robert Zipursky, Stacy Lindborg, and Barry Jones
Am J Psychiatry 2005; 162: 939-946.
[Abstract]
[Full text]
[PDF]
- Articles
Risperidone and Haloperidol in First-Episode Psychosis: A Long-Term Randomized Trial
- Nina Schooler, Jonathan Rabinowitz, Michael Davidson, Robin Emsley, Philip D. Harvey, Lili Kopala, Patrick D. McGorry, Ilse Van Hove, Marielle Eerdekens, Wim Swyzen, Goedele De Smedt, and the Early Psychosis Global Working Group
Am J Psychiatry 2005; 162: 947-953.
[Abstract]
[Full text]
[PDF]
- Articles
A Double-Blind, Placebo-Controlled Trial of Sibutramine for Olanzapine-Associated Weight Gain
- David C. Henderson, Paul M. Copeland, Tara B. Daley, Christina P. Borba, Corrine Cather, Dana D. Nguyen, Pearl M. Louie, A. Eden Evins, Oliver Freudenreich, Doug Hayden, and Donald C. Goff
Am J Psychiatry 2005; 162: 954-962.
[Abstract]
[Full text]
[PDF]
- Brief Reports
Predominant Role of the 9-Hydroxy Metabolite of Risperidone in Elevating Blood Prolactin Levels
- Rikus Knegtering, Pepijn Baselmans, Stynke Castelein, Fokko Bosker, Richard Bruggeman, and Robert J. van den Bosch
Am J Psychiatry 2005; 162: 1010-1012.
[Abstract]
[Full text]
[PDF]
- Brief Reports
The Effects of Clozapine and Risperidone on Spatial Working Memory in Schizophrenia
- Susan R. McGurk, Cameron Carter, Robert Goldman, Michael F. Green, Stephen R. Marder, Haiyi Xie, Nina R. Schooler, and John M. Kane
Am J Psychiatry 2005; 162: 1013-1016.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
Quetiapine Discontinuation Syndrome
- DEBORAH R. KIM and JEFFREY P. STAAB
Am J Psychiatry 2005; 162: 1020.
[Full text]
[PDF]
- Letters to the Editor
Olanzapine Augmentation of Fluoxetine in Body Dysmorphic Disorder
- KATHARINE A. PHILLIPS
Am J Psychiatry 2005; 162: 1022-a-1023-a.
[Full text]
[PDF]
- Letters to the Editor
Psychotropic Medication and Stroke Outcome
- CHUAN-SHENG ZHAO, KIRSI PUURUNEN, JUHANI SIVENIUS, JUKKA JOLKKONEN, and TIMOTHY SCHALLERT
Am J Psychiatry 2005; 162: 1026-a-1027-a.
[Full text]
[PDF]
- Letters to the Editor
Dr. Herrmann and Colleagues Reply
- NATHAN HERRMANN, KRISTA L. LANCTÔT, and MUHAMMAD MAMDANI
Am J Psychiatry 2005; 162: 1027-a-1028-a.
[Full text]
[PDF]
|
|
